Literature DB >> 30632766

Role of matrix metalloproteinases and histone deacetylase in oxidative stress-induced degradation of the endothelial glycocalyx.

Mohamed M Ali1,2, Abeer M Mahmoud1,2, Elizabeth Le Master3, Irena Levitan3, Shane A Phillips1,2,4.   

Abstract

The glycocalyx is crucial for normal endothelial function. It also tethers extracellular superoxide dismutase (SOD3), which protects the endothelium against oxidative damage. Proteolytic enzymes [matrix metalloproteinases (MMPs)] are capable of disrupting endothelial cell surface proteins, such as syndecans, resulting in derangements of the endothelial glycocalyx. We sought to test the role of MMPs in oxidative stress-mediated disruption of the endothelial glycocalyx and examine the effect of pharmacological inhibition of MMPs on mitigating this detrimental effect. We also examined the role of histone deacetylase (HDAC) in the oxidative stress-mediated MMP induction and glycocalyx remodeling. Oxidative stress was experimentally induced in human adipose microvascular endothelial cells using H2O2 and buthionine sulfoximine in the presence and absence of potent MMP and HDAC inhibitors. H2O2 and buthionine sulfoximine resulted in a notable loss of the endothelial glycocalyx; they also increased the expression and proteolytic activity of MMP-2 and MMP-9 and subsequently increased the shedding of syndecan-1 and SOD3 from the endothelial cell surface. MMP upregulation was accompanied by a decline in mRNA and protein levels of their inhibitors, tissue inhibitors of metalloproteinase (TIMPs; TIMP-1 and TIMP-3). Furthermore, oxidative stress induced HDAC activity. Inhibition of MMPs and HDAC reversed syndecan-1 and SOD3 shedding and maintained endothelial glycocalyx integrity. HDAC inhibition increased TIMP expression and reduced MMP expression and activity in endothelial cells. Our findings shed light on MMPs and HDAC as therapeutically targetable mechanisms in oxidative stress-induced glycocalyx remodeling. NEW & NOTEWORTHY Oxidative stress, a hallmark of many diseases, damages the endothelial glycocalyx, resulting in vascular dysfunction. Studying the mechanistic link between oxidative stress and endothelial glycocalyx derangements might help discover new therapeutic targets to preserve vascular function. In this study, we investigated the involvement of matrix metalloproteinases and histone deacetylase in oxidative stress-induced endothelial glycocalyx degradation.

Entities:  

Keywords:  endothelial glycocalyx; histone deacetylase; matrix metalloproteinase; oxidative stress; superoxide dismutase

Mesh:

Substances:

Year:  2019        PMID: 30632766      PMCID: PMC6459309          DOI: 10.1152/ajpheart.00090.2018

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  63 in total

Review 1.  Marimastat: the clinical development of a matrix metalloproteinase inhibitor.

Authors:  W P Steward; A L Thomas
Journal:  Expert Opin Investig Drugs       Date:  2000-12       Impact factor: 6.206

Review 2.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.

Authors:  Robert Visse; Hideaki Nagase
Journal:  Circ Res       Date:  2003-05-02       Impact factor: 17.367

Review 3.  Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases.

Authors:  Isaac K Sundar; Hongwei Yao; Irfan Rahman
Journal:  Antioxid Redox Signal       Date:  2012-11-06       Impact factor: 8.401

4.  Heart failure biomarkers in patients with dilated cardiomyopathy.

Authors:  Agata Bielecka-Dabrowa; Stephan von Haehling; Wilbert S Aronow; Mustafa I Ahmed; Jacek Rysz; Maciej Banach
Journal:  Int J Cardiol       Date:  2013-02-14       Impact factor: 4.164

Review 5.  Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases.

Authors:  Bernhard F Becker; Matthias Jacob; Stephanie Leipert; Andrew H J Salmon; Daniel Chappell
Journal:  Br J Clin Pharmacol       Date:  2015-05-22       Impact factor: 4.335

Review 6.  Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome.

Authors:  Charles B Jones; David C Sane; David M Herrington
Journal:  Cardiovasc Res       Date:  2003-10-01       Impact factor: 10.787

Review 7.  A class of their own: exploring the nondeacetylase roles of class IIa HDACs in cardiovascular disease.

Authors:  Lillianne H Wright; Donald R Menick
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-20       Impact factor: 4.733

8.  Metabolism of a highly selective gelatinase inhibitor generates active metabolite.

Authors:  Mijoon Lee; Adriel Villegas-Estrada; Giuseppe Celenza; Bill Boggess; Marta Toth; Gloria Kreitinger; Christopher Forbes; Rafael Fridman; Shahriar Mobashery; Mayland Chang
Journal:  Chem Biol Drug Des       Date:  2007-10-10       Impact factor: 2.817

9.  The effect of doxycycline on shedding of the glycocalyx due to reactive oxygen species.

Authors:  Herbert H Lipowsky; Anne Lescanic
Journal:  Microvasc Res       Date:  2013-07-27       Impact factor: 3.514

10.  Loss of the endothelial glycocalyx links albuminuria and vascular dysfunction.

Authors:  Andrew H J Salmon; Joanne K Ferguson; James L Burford; Haykanush Gevorgyan; Daisuke Nakano; Steven J Harper; David O Bates; Janos Peti-Peterdi
Journal:  J Am Soc Nephrol       Date:  2012-07-12       Impact factor: 10.121

View more
  20 in total

1.  Effect of genetic depletion of MMP-9 on neurological manifestations of hypertension-induced intracerebral hemorrhages in aged mice.

Authors:  Stefano Tarantini; Andriy Yabluchanskiy; Anna Csiszar; Zoltan Ungvari; Merry L Lindsey
Journal:  Geroscience       Date:  2021-08-19       Impact factor: 7.713

2.  A prospective study on hyperhomocysteinemia as an aggravating factor in chronic venous insufficiency.

Authors:  Maria Rotaru; Gabriela Mariana Iancu; Ioana Baldovin
Journal:  Exp Ther Med       Date:  2022-05-17       Impact factor: 2.751

Review 3.  The Endothelial Glycocalyx: A Possible Therapeutic Target in Cardiovascular Disorders.

Authors:  Anastasia Milusev; Robert Rieben; Nicoletta Sorvillo
Journal:  Front Cardiovasc Med       Date:  2022-05-13

4.  Minimal Change Disease Is Associated With Endothelial Glycocalyx Degradation and Endothelial Activation.

Authors:  Colin Bauer; Federica Piani; Mindy Banks; Flor A Ordoñez; Carmen de Lucas-Collantes; Kaori Oshima; Eric P Schmidt; Igor Zakharevich; Alfons Segarra; Cristina Martinez; Carlos Roncal-Jimenez; Simon C Satchell; Petter Bjornstad; Marshall Scott Lucia; Judith Blaine; Joshua M Thurman; Richard J Johnson; Gabriel Cara-Fuentes
Journal:  Kidney Int Rep       Date:  2021-12-16

5.  Hyperglycemia-induced effects on glycocalyx components in the retina.

Authors:  Gaganpreet Kaur; Janet Rogers; Nabil A Rashdan; Diana Cruz-Topete; Christopher B Pattillo; Steven D Hartson; Norman R Harris
Journal:  Exp Eye Res       Date:  2021-11-18       Impact factor: 3.770

6.  Glycocalyx degradation and the endotheliopathy of viral infection.

Authors:  Sharven Taghavi; Sarah Abdullah; Farhana Shaheen; Lauren Mueller; Brennan Gagen; Juan Duchesne; Chad Steele; Derek Pociask; Jay Kolls; Olan Jackson-Weaver
Journal:  PLoS One       Date:  2022-10-19       Impact factor: 3.752

7.  Antioxidant Mechanism of Xiaojin Pill () for Treatment of Peyronie's Disease in Rats Based on Matrix Metalloproteinases.

Authors:  Qiang Geng; Fu Wang; Qiang Han; Shao-Feng Chen; Bin Ouyang; Zhong Li; Yu Zhao; Qing-He Gao; Guo-Jin Yu; Jun Guo
Journal:  Chin J Integr Med       Date:  2019-10-24       Impact factor: 1.978

Review 8.  Role of Neutrophil Extracellular Traps and Vesicles in Regulating Vascular Endothelial Permeability.

Authors:  Yonggang Ma; Xiaoyuan Yang; Victor Chatterjee; Jamie E Meegan; Richard S Beard; Sarah Y Yuan
Journal:  Front Immunol       Date:  2019-05-09       Impact factor: 7.561

9.  Blocking matrix metalloproteinase-mediated syndecan-4 shedding restores the endothelial glycocalyx and glomerular filtration barrier function in early diabetic kidney disease.

Authors:  Raina D Ramnath; Matthew J Butler; Georgina Newman; Sara Desideri; Amy Russell; Abigail C Lay; Chris R Neal; Yan Qiu; Sarah Fawaz; Karen L Onions; Monica Gamez; Michael Crompton; Chris Michie; Natalie Finch; Richard J Coward; Gavin I Welsh; Rebecca R Foster; Simon C Satchell
Journal:  Kidney Int       Date:  2019-11-02       Impact factor: 10.612

Review 10.  Histone Deacetylases (HDACs) and Atherosclerosis: A Mechanistic and Pharmacological Review.

Authors:  Xiaona Chen; Yanhong He; Wenjun Fu; Amirhossein Sahebkar; Yuhui Tan; Suowen Xu; Hong Li
Journal:  Front Cell Dev Biol       Date:  2020-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.